Middle East And Africa Western Blotting Market Forecast Analysis 2024-2032
Triton’s analysis estimated that the Middle East and Africa western blotting market is set to garner revenue at 4.65% CAGR over the forecast years 2024-2032.
The Middle East and Africa region face challenges in meeting HIV targets by 2025, as new infections are rising and only 50% of people living with HIV have access to treatment, with women and children receiving even less coverage. The low diagnosis and treatment rates will drive a growing demand for western blotting techniques in the region, as they are essential for accurate HIV diagnosis and monitoring, aiding efforts to control the epidemic. With the region’s delayed HIV diagnoses and inadequate treatment coverage, the western blotting process will become increasingly vital for early detection, improving patient outcomes and supporting public health initiatives aimed at reversing the epidemic’s growth.
The countries examined in this region include the United Arab Emirates, Saudi Arabia, Turkey, South Africa, and Rest of Middle East & Africa.
Saudi Arabia leads with the highest market share, accounting for nearly $5.11 million in 2023.
- The rising incidence of chronic and infectious diseases, such as cancer and diabetes, in Saudi Arabia drives the demand for advanced diagnostic techniques like western blotting, which is crucial for protein detection and disease research.
- The government’s focus on advancing healthcare infrastructure and promoting research in life sciences and biotechnology encourages the use of western blotting in academic and clinical research settings.
- These factors collectively fuel the growth of the western blotting market in the country by increasing the need for high-quality diagnostic tools and promoting innovation in the healthcare and research sectors.
Western Blotting Market Trends in the United Arab Emirates
As the government in the United Arab Emirates continues to enhance its healthcare facilities, the demand for advanced laboratory techniques like western blotting grows, creating market opportunities for suppliers of western blotting equipment and consumables. Heavy investments in healthcare research, especially in the biotechnology and molecular biology sectors, lead to a higher demand for western blotting methods to support ongoing studies in protein expression and disease mechanisms.
The market segments for western blotting consist of end-user, product type, and application. The end-user segment includes end-user segment comprises research institutes, diagnostic centers, pharmaceutical & biotechnology companies, and other end-users. Research institutes are experiencing strong growth, driven largely by the widespread adoption of protein detection methods in test samples for biomedical research, molecular biology, immunogenetics, etc. This technique is highly effective in detecting and isolating various key proteins, especially those that are less abundant in critical diagnostic samples.
Contender Analysis in the Western Blotting Market:
Merck KGaA is a science and technology company that provides innovative, personalized treatments for various serious diseases. In addition, it offers digital platforms, tools, and services aimed at simplifying research and enabling scientific breakthroughs. Founded in 1668, Merck’s business spans life sciences, healthcare, and electronics, with a strong presence across Europe, North America, Asia-Pacific, Latin America, and the Middle East and Africa. The headquarters are situated in Darmstadt, Germany.
The company offers several products mainly categorized into Protein detection system, Protein preparation, and Transfer membranes.
Some other notable contenders in the western blotting market are Li-Cor Inc, Advansta Inc, Cell Signaling Technology Inc, Azure Biosystems Inc, and PerkinElmer Inc.